Federal departments or organizations which have been or will be communicated with during the course of the undertaking:
|
Canadian Heritage (PCH),
Canadian International Development Agency (CIDA),
Correctional Service of Canada (CSC),
Health Canada (HC),
Human Resources and Social Development Canada (HRSDC),
Human Resources Development Canada (HRDC),
Members of the House of Commons,
Patented Medicine Prices Review Board (PMPRB),
Prime Minister's Office (PMO),
Privy Council Office (PCO),
Senate of Canada,
Service Canada (ServCan),
Veterans Affairs Canada (VAC)
|
Communication techniques that have been used or are expected to be used in the course of the undertaking:
|
Grass-roots communication,
Informal communications,
Meetings,
Presentations,
Telephone calls,
Written communications, whether in hard copy or electronic format
|
|
Subject Matter: Areas of Concern:
|
Aboriginal Affairs,
Education,
Health,
International Relations,
Social Policy
|
|
Subject Matter: Retrospective:
|
1. December 10th, 2007 - Meeting with the Honourable Christiane Gagnon (MP) 2. December 4th, 2007 - Meeting with Ms. Dani Shaw, Director of Policy, Minister of Health 3. February 1st, 2008 - Corresondence regarding the proposal redarding the regulation of tramadol under the controlled substances act.4. April 7, 2008 - Presentation (invitation) to the Senate Committee on Aging
|
Subject Matter: Prospective:
|
- In the event of a national general election the CHPCA will be sending correspondence to each of the federal political parties.- May 2008 - Information Kits to MPs and Senators for National Hospice Palliative Care Week.
|
|
Details Regarding the Identified Subject Matter
Categories
|
Description
|
Policy or Program
|
April 7, 2008 - Presentation (invitation) to the Senate Committee on Aging
|
Policy or Program
|
December 10th, 2007 - Meeting with the Honourable Christiane Gagnon (MP)
|
Policy or Program
|
December 4th, 2007 - Meeting with Ms. Dani Shaw, Director of Policy, Minister of Health
|
Regulation
|
February 1st, 2008 - Corresondence regarding the proposal redarding the regulation of tramadol under the controlled substances act.
|
|